|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Prolonged intrauterine contraception: a seven-year randomized study of the |
| levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. |
| Sivin I; Stern J; Coutinho E; Mattos CE; El Mahgoub S; Diaz S; Pavez M; |
| Alvarez F; Brache V; Thevenin F |
| CONTRACEPTION. 1991 Nov;44(5):473-80. |
| A levonorgestrel-releasing IUD and the Copper T 380Ag IUD were randomly compared for 7 years in 5 clinics. In 2 |
| other clinics, the randomized study was truncated at 5 years, but the use of the Copper T continued. No pregnancies |
| occurred to users of either device in years 6 and 7. Cumulative pregnancy rates were 1.1/100 at 7 years for the |
| steroid-releasing and 1.4/100 for the copper-releasing IUDs. Cumulative rates for pelvic inflammatory disease did not |
| differ between devices. Infection rates appeared to be lowest during the 6th and 7th years of the study. Termination |
| attributable to amenorrhea was the principle contributor to differences in cumulative continuation rates between |
| devices. At the 5 clinics which continued the comparative study for 7 years, cumulative continuation rates were |
| 24.9/100 for LNg20 IUD users and 29.4/100 for TCu 380Ag users. Women who used either method for periods of 5-7 |
| years experienced, on the average, marked to mild increases in hemoglobin as compared to levels measured at |
| admission. The Copper T380 family and the LNg20 IUDs represent the most effective reversible contraceptive |
| methods yet studied in longterm randomized trials. (author's) (PubHealth.info Document ID: CONT3T 2016-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Prolonged intrauterine contraception: a seven-year |
| randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.", is(are) Sivin I; Stern J; |
| Coutinho E; Mattos CE; El Mahgoub S; Diaz S; Pavez M; Alvarez F; Brache V; Thevenin F. The source of this |
| article is "CONTRACEPTION. 1991 Nov;44(5):473-80.". This article was published in 1991 in English language(s). |
| (PubHealth.info® Document ID: CONT3T 2016-06. All rights reserved with PubHealth.info) PIN: 12016 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
